Clinical Pharmacology of Serotonin Receptor Type 3 (5-HT3) Antagonists

By  

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 1, Iss. 2, 2001-08 ,pp. : 171-199

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical Pharmacokinetics of Tegaserod, a Serotonin 5-HT Receptor Partial Agonist with Promotile Activity

By Appel-Dingemanse S.  

Clinical Pharmacokinetics, Vol. 41, Iss. 13, 2002-01 ,pp. : 1021-1042

Adis International

Access to resources Recommend Favorite

Clinical Pharmacokinetics of Almotriptan, a Serotonin 5-HT 1B/1D Receptor Agonist for the Treatment of Migraine

By McEnroe Janet D.   Fleishaker Joseph C.  

Clinical Pharmacokinetics, Vol. 44, Iss. 3, 2005-01 ,pp. : 237-246

Adis International

Access to resources Recommend Favorite

Zolmitriptan (a 5-HT receptor agonist with central action) does not increase symptoms in obsessive compulsive disorder

By Boshuisen M.L.   den Boer J.A.  

Psychopharmacology, Vol. 152, Iss. 1, 2000-09 ,pp. : 74-79

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacology of U-91356A, an agonist for the dopamine D 2 receptor subtype

By Piercey M.F.   Moon M.W.   Sethy V.H.   Schreur P.J.K.D.   Smith M.W.   Tang A.H.   VonVoigtlander P.F.  

European Journal of Pharmacology, Vol. 317, Iss. 1, 1996-12 ,pp. : 29-38

Elsevier

Access to resources Recommend Favorite